Virtual-Strategy Magazine (press release) Vosaroxin is a first-in-class anti-cancer quinolone derivative (AQD), a class of compounds that has not been used previously for the treatment of cancer. Vosaroxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, ... and more »
RTT News Vosaroxin is an anti-cancer quinolone derivative, a class of compounds that has not been used previously for the treatment of cancer. The Phase I/II, open-label, dose escalating trial is expected to enroll up to about 40 partients with MDS, who have ...
GlobeNewswire (press release) Vosaroxin is a first-in-class anti-cancer quinolone derivative (AQD), a class of compounds that has not been used previously for the treatment of cancer. Vosaroxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, ... and more »
MarketWatch Vosaroxin is a first-in-class anti-cancer quinolone derivative (AQD), a class of compounds that has not been used previously for the treatment of cancer. Vosaroxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, ... and more »
